Suppr超能文献

人凝集素-1(ITLN1)的遗传变异与肠道表达。

Human intelectin-1 (ITLN1) genetic variation and intestinal expression.

机构信息

Department of Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, CA, 95616, USA.

Elanco Animal Health, Fort Dodge, IA, 50501, USA.

出版信息

Sci Rep. 2021 Jun 18;11(1):12889. doi: 10.1038/s41598-021-92198-9.

Abstract

Intelectins are ancient carbohydrate binding proteins, spanning chordate evolution and implicated in multiple human diseases. Previous GWAS have linked SNPs in ITLN1 (also known as omentin) with susceptibility to Crohn's disease (CD); however, analysis of possible functional significance of SNPs at this locus is lacking. Using the Ensembl database, pairwise linkage disequilibrium (LD) analyses indicated that several disease-associated SNPs at the ITLN1 locus, including SNPs in CD244 and Ly9, were in LD. The alleles comprising the risk haplotype are the major alleles in European (67%), but minor alleles in African superpopulations. Neither ITLN1 mRNA nor protein abundance in intestinal tissue, which we confirm as goblet-cell derived, was altered in the CD samples overall nor when samples were analyzed according to genotype. Moreover, the missense variant V109D does not influence ITLN1 glycan binding to the glycan β-D-galactofuranose or protein-protein oligomerization. Taken together, our data are an important step in defining the role(s) of the CD-risk haplotype by determining that risk is unlikely to be due to changes in ITLN1 carbohydrate recognition, protein oligomerization, or expression levels in intestinal mucosa. Our findings suggest that the relationship between the genomic data and disease arises from changes in CD244 or Ly9 biology, differences in ITLN1 expression in other tissues, or an alteration in ITLN1 interaction with other proteins.

摘要

凝集素是古老的碳水化合物结合蛋白,跨越脊索动物的进化过程,并与多种人类疾病有关。先前的全基因组关联研究(GWAS)已经将 ITLN1(也称为网膜素)中的 SNP 与克罗恩病(CD)的易感性联系起来;然而,对该基因座中 SNP 可能的功能意义的分析仍然缺乏。利用 Ensembl 数据库,对 ITLN1 基因座中与疾病相关的 SNP 进行了两两连锁不平衡(LD)分析,包括 CD244 和 Ly9 中的 SNP。构成风险单倍型的等位基因在欧洲人中是主要等位基因(67%),但在非洲超级人群中是次要等位基因。ITLN1 在肠道组织中的 mRNA 或蛋白丰度并没有改变,我们证实这些蛋白是由杯状细胞衍生而来,在整个 CD 样本中都没有改变,也没有根据基因型对样本进行分析。此外,错义变体 V109D 并不影响 ITLN1 聚糖与聚糖β-D-半乳糖呋喃糖的结合或蛋白-蛋白寡聚化。总之,我们的数据通过确定风险不太可能是由于 ITLN1 碳水化合物识别、蛋白寡聚化或肠黏膜表达水平的变化而导致的,从而为确定 CD 风险单倍型的作用迈出了重要的一步。我们的发现表明,基因组数据与疾病之间的关系源于 CD244 或 Ly9 生物学的变化、其他组织中 ITLN1 表达的差异,或 ITLN1 与其他蛋白相互作用的改变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c852/8213764/d4e2c7574801/41598_2021_92198_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验